BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  BD Breaks Ground on $60M Expansion of Nebraska Manufacturing Facility

  The expansion will transform the Columbus-East facility into the flagship plastic injection molding manufacturing facility for BD.

  October 25, 2017

   · 

  3 min read
• Business

  Amarin to Report Third Quarter 2017 Results and Host Conference Call on November 1, 2017

  The conference call will follow the anticipated release of the company’s financial results earlier that day.

  October 25, 2017

   · 

  3 min read
• Biotech Bay

  Sunesis Announces Proposed Public Offering of Common Stock, Preferred Stock and Warrants

  Sunesis anticipates using the net proceeds from the proposed offerings to fund the continued development of their pipeline.

  October 25, 2017

   · 

  3 min read
• Business

  Notal Vision Welcomes Distinguished Retinal Specialist John S. Pollack, MD, to the Board of Directors

  Notal Vision today announced that John S. Pollack, MD, an internationally recognized retinal clinician, surgeon, and educator, has been elected to Notal’s Board of Directors.

  October 25, 2017

   · 

  4 min read
• Business

  TSO3 Sets Third Quarter Earnings Call for Tuesday, November 7, 2017 at 8:30 a.m. EST

  TSO3 will hold a conference call on Tuesday, November 7, 2017, to discuss its financial results for the third quarter ended September 30, 2017.

  October 25, 2017

   · 

  2 min read
• Business

  OncoSec Announces Fourth Quarter and Year End Financial Results for Fiscal Year 2017

  OncoSec Medical today announced financial results for the fourth quarter and fiscal year ended July 31, 2017.

  October 25, 2017

   · 

  24 min read
• Policy

  Shingrix with QS-21 Stimulon Receives Positive Recommendation from CDC’s Advisory Committee on Immunization Practices as Preferred Vaccine for Prevention of Shingles

  Agenus announced today that the CDC’s ACIP voted in favor of three recommendations for the use of Shingrix containing QS-21 Stimulon for the prevention of shingles.

  October 25, 2017

   · 

  4 min read
• Business

  Juno Therapeutics to Report Third Quarter 2017 Financial Results on Wednesday, November 1

  Juno Therapeutics, Inc. will announce financial results for the third quarter 2017 on Wednesday, November 1, 2017, after the close of U.S.-based financial markets.

  October 25, 2017

   · 

  4 min read
• Drug Development

  Anika Completes Enrollment in Second Pivotal Phase III Trial of CINGAL for the Treatment of Knee Pain Associated With Osteoarthritis

  Anika Therapeutics today announced the completion of enrollment in its second pivotal Phase III trial evaluating CINGAL, its novel HA-corticosteroid combination viscosupplement1 for the treatment of symptoms associated with osteoarthritis (“OA”) of the knee.

  October 25, 2017

   · 

  5 min read
• Business

  Innoviva Reports Third Quarter 2017 Financial Results and Provides Business Updates

  Innoviva reported financial results for the third quarter of 2017. Gross royalties earned on net sales of RELVAR/BREO ELLIPTA and ANORO ELLIPTA from Glaxo Group Limited (GSK) during the third quarter of 2017 were $51.9 million, up 42% from $36.5 million in the third quarter of 2016.

  October 25, 2017

   · 

  16 min read